Samuel Kintz
Fondatore presso ENLIVEN THERAPEUTICS, INC.
Patrimonio netto: 21 M $ in data 30/04/2024
Profilo
Samuel S.
Kintz is the founder of Enliven Therapeutics, Inc. (founded in 2019) and currently holds the titles of President, Chief Executive Officer & Director.
Mr. Kintz's education history includes an undergraduate degree from Stanford University and an MBA from Stanford Graduate School of Business.
Mr. Kintz is also the founder of Enliven Therapeutics, Inc...
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 25/04/2024 | 1 264 587 ( 2.70% ) | 21 M $ | 30/04/2024 |
Posizioni attive di Samuel Kintz
| Società | Posizione | Inizio |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Fondatore | 01/06/2019 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Fondatore | - |
Formazione di Samuel Kintz
| Stanford University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Samuel Kintz
